|
1. The Immune Response to Opportunistic Fungal Infections1. The Immune Response to Opportunistic Fungal Infections
|
by
Dr Shmuel Shoham and Dr Stuart M. Levitz
Fungi have emerged as a major cause of infection, particularly among immune compromised patients
...
Learn More
|
CME Credits
0.75
AMA PRA
Category 1 Credits™
|
|
|
2. Mechanisms of Action of Antifungal Agents2. Mechanisms of Action of Antifungal Agents
|
by
Dr David A. Stevens and Dr Tony Mazzulli
The relatively unique structure of the fungal cell wall and cell membrane provide specific targets for many antifungal agents, not found in most other infectious agents or in human cells
...
Learn More
|
CME Credits
0.50
AMA PRA
Category 1 Credits™
|
|
|
3.
Invasive Candida Infections3.
Invasive Candida Infections
|
by
Dr Coleman Rotstein
Clinical manifestations of Candida infections include: candidemia, invasive candidiasis, disseminated candidiasis and candiduria
...
Learn More
|
CME Credits
1.25
AMA PRA
Category 1 Credits™
|
|
|
4. Invasive Aspergillosis4. Invasive Aspergillosis
|
by
Dr Thomas F. Patterson and Dr George R. Thompson III
Aspergillosis is caused by the hyaline mold Aspergillus, which is responsible not only for invasive aspergillosis but also a variety of noninvasive or semi-invasive conditions
...
Learn More
|
CME Credits
2.25
AMA PRA
Category 1 Credits™
|
|
|
5. Zygomycosis5. Zygomycosis
|
by
Dr Luis Ostrosky-Zeichner
Zygomycosis is a term for a variety of fungal infections caused by members of the orders Mucorales and Entomophthorales
...
Learn More
|
CME Credits
0.50
AMA PRA
Category 1 Credits™
|
|
|
6. Treatment of Candidemia/Invasive Candidiasis and Candiduria6. Treatment of Candidemia/Invasive Candidiasis and Candiduria
|
by
Dr Coleman Rotstein
The Infectious Diseases Society of America Guidelines for the Treatment for Candidemia/Invasive Candidiasis state that for stable patients
...
Learn More
|
CME Credits
1.50
AMA PRA
Category 1 Credits™
|
|
|
7. Treatment of Invasive Aspergillosis7. Treatment of Invasive Aspergillosis
|
by
Dr Thomas F. Patterson and Dr George R. Thompson III
Amphotericin B (AmB), the 3 lipid formulations of AmB (AmB colloidal dispersion, AmB lipid complex, and liposomal AmB), itraconazole, posaconazole, voriconazole
...
Learn More
|
CME Credits
2.00
AMA PRA
Category 1 Credits™
|
|